Risk and safety profile in checkpoint inhibitors on non-small-cell lung cancer: A systematic review

Treating non-small-cell lung cancer (NSCLC) has gained increased importance in recent years due to the high mortality rate and dismal five-year survival rate. Immune checkpoint inhibitors (ICI) are a promising approach with exceptional outcomes in NSCLC thanks to the antigenic nature of cells. Conve...

Podrobná bibliografie
Hlavní autor:	Majernikova, SM
Médium:	Journal article
Jazyk:	English
Vydáno:	Taylor and Francis Group 2024

Podobné jednotky

Comparative effectiveness of immune-checkpoint inhibitors for previously treated advanced non-small cell lung cancer - A systematic review and network meta-analysis of 3024 participants
Autor: Tan, P, a další
Vydáno: (2017)

Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer
Autor: Ferrara, R, a další
Vydáno: (2020)

Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer
Autor: Ferrara, R, a další
Vydáno: (2021)

Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer
Autor: Cron, Kyle R., a další
Vydáno: (2013)

Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
Autor: Dutt, Amit, a další
Vydáno: (2011)

The current status of checkpoint inhibitors in metastatic bladder cancer
Autor: Fahmy Ahmed, Omar Ahmed, a další
Vydáno: (2016)

Systematic review of patient-reported outcome measures used in randomised clinical trials testing checkpoint inhibitor immunotherapy for cancer
Autor: Peters, M, a další
Vydáno: (2018)

A review of ultrasound-mediated checkpoint inhibitor immunotherapy
Autor: Rivera, J, a další
Vydáno: (2023)

Review of hypofractionated small volume radiotherapy for early-stage non-small cell lung cancer.
Autor: Brock, J, a další
Vydáno: (2008)

Qualitative and quantitative approaches to modelling tyrosine kinase inhibitor treatment and resistance in non-small cell lung cancer
Autor: Carrick Smith, EJ
Vydáno: (2021)

Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer
Autor: Ricciuti, Biagio, a další
Vydáno: (2020)

Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
Autor: Christensen, Camilla L., a další
Vydáno: (2017)

Mitochondrial inhibitor atovaquone increases tumor oxygenation and inhibits hypoxic gene expression in patients with non-small cell lung cancer
Autor: Skwarski, M, a další
Vydáno: (2021)

Characterising peripheral responses to immune checkpoint inhibitors
Autor: Cooper, R
Vydáno: (2021)

Efficacy of Afatinib in the treatment of patients with non-small cell lung cancer and head and neck squamous cell carcinoma: a systematic review and meta-analysis
Autor: Maarof, Nian N. N., a další
Vydáno: (2021)

A model informed approach to assess the risk of checkpoint inhibitors induced myocarditis
Autor: ven der Vegt, S, a další
Vydáno: (2022)

Targeting inflammation in non-small cell lung cancer through drug repurposing
Autor: Rajasegaran, Thiviyadarshini, a další
Vydáno: (2023)

Gene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer.
Autor: Hu, J, a další
Vydáno: (2005)

The role of LKB1 (STK11) in non-small cell lung cancer
Autor: Cahill, F
Vydáno: (2017)

Treatment of depression in people with lung cancer: A systematic review
Autor: Walker, J, a další
Vydáno: (2013)

Treatment of depression in people with lung cancer: a systematic review.
Autor: Walker, J, a další
Vydáno: (2013)

Synergy of ruthenium metallo-intercalator, [Ru(dppz)2(PIP)]2+, with PARP inhibitor Olaparib in non-small cell lung cancer cells
Autor: Yusoh, Nur Aininie, a další
Vydáno: (2023)

Lung cancer risk and solid fuel smoke exposure: a systematic review and meta-analysis.
Autor: Kurmi, O, a další
Vydáno: (2012)

Cavitation-mediated immunomodulation and its use with checkpoint inhibitors
Autor: Maardalen, M, a další
Vydáno: (2023)

Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.
Autor: Guckenberger, M, a další
Vydáno: (2012)

Cisplatin and vinorelbine in the treatment of locally advanced and metastatic non-small cell lung cancer
Autor: Wong, Catherine Mee Ming, a další
Vydáno: (2001)

Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer
Autor: Papagiannakopoulos, Thales, a další
Vydáno: (2018)

Non-small-cell lung cancer dimensions: CT-pathological correlation and interobserver variation.
Autor: Macpherson, R, a další
Vydáno: (2009)

Resolution of non–small-cell lung cancer after withdrawal of anti-TNF therapy
Autor: Lees, C, a další
Vydáno: (2008)

Prognostic value of nonangiogenic and angiogenic growth patterns in non-small-cell lung cancer.
Autor: Sardari Nia, P, a další
Vydáno: (2004)

Dose escalation for non-small cell lung cancer: analysis and modelling of published literature.
Autor: Partridge, M, a další
Vydáno: (2011)

Novel therapeutic strategies for targeting EGFR mutated non-small cell lung cancer
Autor: Drobnitzky, N
Vydáno: (2017)

Smoking as a risk factor for lung cancer in women and men: A systematic review and meta-analysis
Autor: O'Keeffe, L, a další
Vydáno: (2018)

Percutaneous Intratumoral Immunoadjuvant Gel Increases the Abscopal Effect of Cryoablation for Checkpoint Inhibitor Resistant Cancer
Autor: Som, Avik, a další
Vydáno: (2024)

Investigating the initiation and progression of small cell lung cancer
Autor: Brauneis, Alison Dooley
Vydáno: (2011)

CRISPR-mediated interrogation of small cell lung cancer
Autor: Ng, Sheng Rong
Vydáno: (2018)

Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010-2015
Autor: Aznar, M, a další
Vydáno: (2018)

Association between clinical factors and result of immune checkpoint inhibitor related myasthenia gravis: a single center experience and systematic review
Autor: Shi, J, a další
Vydáno: (2022)

A Molecular Docking Study of Epoxyxanthones Toward Non-Small and Small Cell Lung Cancer Target Proteins
Autor: Iresha, M.R., a další
Vydáno: (2022)

Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors
Autor: Ahn, Ryuhjin, a další
Vydáno: (2021)